Q3 FY2026 · ended Sep 30, 2026 · Revenue $211.03M, +58.0% YoY · Filed Oct 28, 2026
GLAUKOS Corp (GKOS) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $211.0 million and net income of $2.0 million. Free cash flow was $36.5 million. As of Sep 30, 2026 it held $336.7 million in cash and investments and $105.1 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GKOS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aliso Viejo, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1192448
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $211.0M | $185.6M | $150.6M | $143.1M | $133.5M |
| Operating income | $828,000 | -$17.3M | -$19.9M | -$139.9M | -$16.4M |
| Net income | $2.0M | -$18.4M | -$19.8M | -$133.7M | -$16.2M |
| Diluted EPS | $0.03 | -$0.31 | -$0.34 | -$2.32 | -$0.28 |
| Operating cash flow | $38.6M | $14.8M | -$12.5M | $6.8M | -$10.1M |
| Free cash flow | $36.5M | $12.1M | -$16.5M | $3.9M | -$11.7M |
| Total assets | $979.5M | $920.5M | $893.3M | $893.5M | $999.4M |
| Total liabilities | $262.3M | $238.0M | $222.4M | $237.3M | $229.8M |
| Stockholders' equity | $717.3M | $682.5M | $670.9M | $656.2M | $769.5M |
| Cash and investments | $336.7M | $286.2M | $276.7M | $278.8M | $273.7M |
| Total debt | $105.1M | $105.9M | $105.9M | $106.5M | $106.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2026 | May 28, 2026 |
All 1014 GLAUKOS Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.